High Dose Therapy in Lymphomas: A Review of the Current Status of Allogeneic and Autologous Stem Cell Transplantation in Hodgkin's Disease and Non-Hodgkin's Lymphoma

High Dose Therapy in Lymphomas: A Review of the Current Status of Allogeneic and Autologous Stem Cell Transplantation in Hodgkin's Disease and Non-Hodgkin's Lymphoma Scott A. Mink, James O. Armitage Oncologist 2001; 6: 247-256 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine regarding lymphomas and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Be familiar with the evolving role of bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas. Understand clinical characteristics which predict poor prognosis in individual lymphoma patients. Appreciate the rationale for using bone marrow transplantation in lymphoma and other malignancies. Know the advantages and disadvantages of allogeneic bone marrow transplantation. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Mar. 20, 2002 Most Recent Review: Mar. 20, 2003* Most Recent Update: Mar. 20, 2002 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.